Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT01613157
Eligibility Criteria:
Inclusion Criteria:
* Are HIV infected
* Are 18 years old or older
* A biologic woman
* Are taking their first combination Anti-retroviral regimen that includes a Protease Inhibitor or a Non-Nucleoside Reverse Transcriptase Inhibitor for the past three months with no changes in any part of the combination in that period
* Are taking either a Protease Inhibitor or an Non-Nucleoside Reverse Transcriptase Inhibitor but not both
* If taking a Protease Inhibitor, must be taking only one Protease Inhibitor excluding low dose ritonavir used as boosting
* Have a viral load \< 50 copies/mL on two occasions at least 1 month apart including a value at least three months before the baseline visit
* Have signed and dated a full informed consent
Exclusion Criteria:
* Have difficulty participating in a trial due to non-adherence or substance abuse
* Pregnant or breast-feeding
* Have malignancy receiving systemic chemotherapy
* Have end-stage organ disease
* Have another significant non-HIV underlying disease that might impinge upon disease progression or death
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01613157
Study Brief:
Protocol Section:
NCT01613157